Genetic mutations involving PSEN1, PSEN2, and APP genes, result in an increased production of aggregatable subtype of Aβ peptide (Aβ11–42), thereby predisposing to AD constituting 5% of total cases [31, 32]. This evidence concerns the gene PSEN1 and Alzheimer disease.